drugset / Trial / NCT02117349

Topical Raplixa for Surgical Bleeding in Children

NCT02117349

Phase 2 Terminated 55 enrolled Mallinckrodt
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to determine if Raplixa plus Gelfoam is better than Gelfoam alone in stopping mild to moderate bleeding in children having surgery.

Timeline

Start
2014-12-04
Primary completion
2017-11-17
Completion
2018-03-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic 2 g Topical

Indications

No indication recorded.